# A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects

> **NCT01146327** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 60 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-04620110
- **DRUG:** PF-04620110
- **DRUG:** PF-04620110
- **DRUG:** PF-04620110
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01146327
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2011-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01146327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01146327, "A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01146327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*